Publications

Detailed Information

Complement depletion with cobra venom factor delays acute cell-mediated rejection in pig-to-mouse corneal xenotransplantation

DC Field Value Language
dc.contributor.authorOh, Joo Youn-
dc.contributor.authorKim, Mee Kum-
dc.contributor.authorLee, Hyun Ju-
dc.contributor.authorKo, Jung Hwa-
dc.contributor.authorPark, Chan-Sik-
dc.contributor.authorPark, Chung-Gyu-
dc.contributor.authorLee, Jin Hak-
dc.contributor.authorWee, Won Ryang-
dc.contributor.authorKim, Sang Joon-
dc.contributor.authorKang, Hee Jung-
dc.contributor.authorKim, Youngji-
dc.date.accessioned2012-06-11T01:56:47Z-
dc.date.available2012-06-11T01:56:47Z-
dc.date.issued2010-04-
dc.identifier.citationXENOTRANSPLANTATION; Vol.17 2; 140-146ko_KR
dc.identifier.issn0908-665X-
dc.identifier.urihttps://hdl.handle.net/10371/76936-
dc.description.abstractBackground: We have demonstrated earlier that porcine corneal xenografts underwent an acute cell-mediated rejection in mice despite the absence of T cells. In the present study, we investigated the effect of complement depletion by cobra venom factor (CVF) on the corneal xenograft rejection in a pig-to-mouse model. Methods: Porcine corneas were orthotopically transplanted into C57BL/6 (B6) and severe combined immunodeficiency (SCID) mice. For complement depletion, 25 mu g of CVF (1 g/kg bodyweight) was injected intraperitoneally on the day before and 1, 3, 5, and 7 days after transplantation. Graft survival was clinically assessed by slit lamp biomicroscopy and the median survival time (MST) was calculated. The grafts were histologically evaluated serially after transplantation using antibodies against CD4, CD8, NK1.1, and F4/80. Results: The CVF treatment significantly prolonged the porcine corneal xenograft survival in both B6 (MST 9.4 vs. 15.5 days; P = 0.0011) and SCID mice (MST 16.4 vs. 20.5 days; P = 0.0474). Histologically, whereas macrophages and CD4(+) T cells were progressively in. ltrated into porcine corneal grafts in CVF-untreated B6 mice, the infiltration by both cells was markedly delayed and decreased in the xenografts in CVF-treated B6 mice. Likewise, macrophage infiltration, which was prominent in rejected porcine xenografts in SCID mice, was also reduced in CVF-treated SCID mice. Conclusions: Our results suggest that complement depletion by CVF delayed, although did not prevent, an acute cell-mediated rejection in a pig-to-mouse corneal xenotransplantation.ko_KR
dc.language.isoenko_KR
dc.publisherWILEY-BLACKWELLko_KR
dc.subjectcobra venom factorko_KR
dc.subjectcomplementko_KR
dc.subjectpigko_KR
dc.subjectmouseko_KR
dc.subjectcorneako_KR
dc.subjectxenotransplantationko_KR
dc.titleComplement depletion with cobra venom factor delays acute cell-mediated rejection in pig-to-mouse corneal xenotransplantationko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor오주윤-
dc.contributor.AlternativeAuthor김미금-
dc.contributor.AlternativeAuthor이현주-
dc.contributor.AlternativeAuthor고정화-
dc.contributor.AlternativeAuthor김영지-
dc.contributor.AlternativeAuthor박찬식-
dc.contributor.AlternativeAuthor강희정-
dc.contributor.AlternativeAuthor박정규-
dc.contributor.AlternativeAuthor김상준-
dc.contributor.AlternativeAuthor이진학-
dc.contributor.AlternativeAuthor위원량-
dc.identifier.doi10.1111/j.1399-3089.2010.00574.x-
dc.citation.journaltitleXENOTRANSPLANTATION-
dc.description.citedreferenceLi SQ, 2009, TRANSPL IMMUNOL, V21, P70, DOI 10.1016/j.trim.2008.10.004-
dc.description.citedreferenceOh JY, 2009, XENOTRANSPLANTATION, V16, P74, DOI 10.1111/j.1399-3089.2009.00514.x-
dc.description.citedreferenceSacks S, 2009, CURR OPIN ORGAN TRAN, V14, P10, DOI 10.1097/MOT.0b013e32831ec551-
dc.description.citedreferencePavlov V, 2008, J IMMUNOL, V181, P4580-
dc.description.citedreferenceSchneider MKJ, 2008, CURR OPIN ORGAN TRAN, V13, P171-
dc.description.citedreferenceRicklin D, 2008, ADV EXP MED BIOL, V632, P273, DOI 10.1007/978-0-387-78952-1_20-
dc.description.citedreferenceSuhr BD, 2007, XENOTRANSPLANTATION, V14, P572, DOI 10.1111/j.1399-3089.2007.00422.x-
dc.description.citedreferenceLee HI, 2007, XENOTRANSPLANTATION, V14, P612, DOI 10.1111/j.1399-3089.2007.00433.x-
dc.description.citedreferenceWasowska BA, 2007, CELL IMMUNOL, V248, P18, DOI 10.1016/j.cellimm.2007.04.009-
dc.description.citedreferenceRood PPM, 2007, TRANSPLANTATION, V83, P202, DOI 10.1097/01.tp.0000250680.36942.c6-
dc.description.citedreferenceCardona K, 2006, NAT MED, V12, P304, DOI 10.1038/nm1375-
dc.description.citedreferenceChen G, 2005, NAT MED, V11, P1295, DOI 10.1038/nm1330-
dc.description.citedreferencePindjakova J, 2005, TRANSPLANT INT, V18, P854, DOI 10.1111/j.1432-2277.2005.00112.x-
dc.description.citedreferenceVogel CW, 2004, MOL IMMUNOL, V41, P191, DOI 10.1016/j.molimm.2004.03.011-
dc.description.citedreferenceAmano S, 2003, CURR EYE RES, V26, P313-
dc.description.citedreferenceTabata T, 2003, TRANSPLANTATION, V75, P607, DOI 10.1097/01.TP.0000053353.03389.1C-
dc.description.citedreferenceXu YY, 2001, P NATL ACAD SCI USA, V98, P14577-
dc.description.citedreferenceMeyer zu Vilsendorf A, 2001, XENOTRANSPLANTATION, V8, P41-
dc.description.citedreferenceBarker RA, 2000, J NEUROSCI, V20, P3415-
dc.description.citedreferenceTANAKA K, 2000, INVEST OPHTH VIS SCI, V41, P10827-
dc.description.citedreferenceLin YA, 1998, NAT MED, V4, P173-
dc.description.citedreferenceMARSH JE, 1998, GRAFT, V1, P193-
dc.description.citedreferenceAhearn JM, 1996, IMMUNITY, V4, P251-
dc.description.citedreferenceCHRUPCALA M, 1994, TRANSPL INT S1, V7, pS650-
dc.description.citedreferenceLEVENTHAL JR, 1993, TRANSPLANTATION, V55, P857-
dc.description.citedreferenceERDEI A, 1991, IMMUNOL TODAY, V12, P332-
dc.description.tc5-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share